P

Inventor

HUNZIKER DANIEL

CH57 patents
⚠️ This page may combine multiple inventors who share the name “HUNZIKER DANIEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

HOFFMANN LA ROCHE

33 patents
US6861440B2Mar 1, 2005

DPP IV inhibitors

HOFFMANN LA ROCHE116 citations98
US9802944B2Oct 31, 2017

Bicyclic compounds as autotaxin (ATX) and lysophosphatidic acid (LPA) production inhibitors

HOFFMANN LA ROCHE20 citations92
US9493486B2Nov 15, 2016

Diazaspirocycloalkane and azaspirocycloalkane

HOFFMANN LA ROCHE21 citations92
US10633384B2Apr 28, 2020

Diazaspirocycloalkane and azaspirocycloalkane

HOFFMANN LA ROCHE12 citations85
US10669285B2Jun 2, 2020

Condensed [1,4] diazepine compounds as autotaxin (ATX) and lysophosphatidic acid (LPA) production inhibitors

HOFFMANN LA ROCHE9 citations84
US10654857B2May 19, 2020

Bicyclic compounds as autotaxin (ATX) and lysophosphatidic acid (LPA) production inhibitors

HOFFMANN LA ROCHE10 citations84
US10640472B2May 5, 2020

Phenoxymethyl derivatives

HOFFMANN LA ROCHE10 citations84
US10669268B2Jun 2, 2020

Bicyclic derivatives

HOFFMANN LA ROCHE9 citations83
US10647719B2May 12, 2020

Bicyclic compounds as dual ATX/CA inhibitors

HOFFMANN LA ROCHE10 citations83
US10676446B2Jun 9, 2020

Bicyclic quinazolinone derivatives

HOFFMANN LA ROCHE9 citations82
US11098048B2Aug 24, 2021

Bicyclic compounds as autotaxin (ATX) and lysophosphatidic acid (LPA) production inhibitors

HOFFMANN LA ROCHE2 citations73
US10849881B2Dec 1, 2020

Octahydro-cyclobuta[1,2-c;3,4-c′]dipyrrol-2-yl

HOFFMANN LA ROCHE3 citations73
US10913745B2Feb 9, 2021

Octahydro-pyrrolo[3,4-c]-pyrrole derivatives and analogs thereof as autotaxin inhibitors

HOFFMANN LA ROCHE3 citations72
US10889588B2Jan 12, 2021

Bicyclic compounds as dual ATX/CA inhibitors

HOFFMANN LA ROCHE3 citations72
US10800786B2Oct 13, 2020

Bicyclic compounds as ATX inhibitors

HOFFMANN LA ROCHE4 citations72
US10787459B2Sep 29, 2020

Bicyclic compounds as ATX inhibitors

HOFFMANN LA ROCHE4 citations72
US10738053B2Aug 11, 2020

Bicyclic compounds as dual ATX/CA inhibitors

HOFFMANN LA ROCHE5 citations72
US10882857B2Jan 5, 2021

Bicyclic compounds as ATX inhibitors

HOFFMANN LA ROCHE3 citations71
US11059794B2Jul 13, 2021

Heterocyclic compounds useful as dual ATX/CA inhibitors

HOFFMANN LA ROCHE2 citations69
US7678795B2Mar 16, 2010

Pyridazines as 11b-HSD1 inhibitors

HOFFMANN LA ROCHE6 citations63
US7547697B2Jun 16, 2009

Alkyl-pyridazine derivatives as 11b-HSD1 inhibitors

HOFFMANN LA ROCHE2 citations63
US11352330B2Jun 7, 2022

Phenoxymethyl derivatives

HOFFMANN LA ROCHE1 citations62
US7528159B2May 5, 2009

5-aryl pyridines as 11-beta inhibitors for the treatment of diabetes

HOFFMANN LA ROCHE2 citations62
US7411093B2Aug 12, 2008

Aminocycloalkanes as DPP-IV inhibitors

HOFFMANN LA ROCHE4 citations62
US7314884B2Jan 1, 2008

DPP IV inhibitors

HOFFMANN LA ROCHE2 citations62
US11673888B2Jun 13, 2023

Bicyclic compounds as ATX inhibitors

HOFFMANN LA ROCHE0 citations61
US12116349B2Oct 15, 2024

Methylquinazolinone derivatives

HOFFMANN LA ROCHE0 citations59
US12509467B2Dec 30, 2025

CGAS inhibiting triazolopyrimidone derivatives

HOFFMANN LA ROCHE0 citations52
US7803819B2Sep 28, 2010

DPP IV inhibitors

HOFFMANN LA ROCHE0 citations52
US7683079B2Mar 23, 2010

4-aminopiperidine derivatives

HOFFMANN LA ROCHE1 citations52
US7507733B2Mar 24, 2009

11b-HSD1 inhibitors for the treatment of diabetes

HOFFMANN LA ROCHE1 citations52
US7482341B2Jan 27, 2009

Pyridines

HOFFMANN LA ROCHE1 citations52
US12570615B2Mar 10, 2026

Quinazolinone derivatives

HOFFMANN LA ROCHE0 citations49

ACKERMANN JEAN

7 patents

HUNZIKER DANIEL

4 patents

C4 THERAPEUTICS INC

2 patents

BAILLY JACQUES

2 patents

BASILEA PARMACEUTICA AG

1 patent

CONTE AURELIA

1 patent

Showing the top 50 of 57 patents by PatentIndex Score.